Refractory amiodarone-associated thyrotoxicosis: An indication for thyroidectomy

Australian and New Zealand Journal of Surgery

Volumn 70, Issue 3, 2000, Pages 174-178

  Claxton, Scott ^a   Sinha, Sankar N ^a   Donovan, Shaun ^a   Greenaway, Timothy M ^a   Hoffman, Linda ^a   Loughhead, Michael ^a   Burgess, John R ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

Amiodarone; Complications; Thyroidectomy; Thyrotoxicosis; Treatment

Indexed keywords

AMIODARONE; COLESTYRAMINE; DEXAMETHASONE; LITHIUM CARBONATE; PROPYLTHIOURACIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; HUMANS; MALE; MIDDLE AGED; TASMANIA; THYROID GLAND; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 0034036417     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2000.01780.x     Document Type: Article

References (17)

1. 1. Iervasi G, Clerico A, Bonini R et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J. Clin. Endocrinol. Metab. 1997; 82: 275-80.
2. 2. Rao RH, McCready VR, Spathis GS. Iodine kinetic studies during amiodarone treatment. J. Clin. Endocrinol. Metab. 1986; 62: 563-8.
3. 3. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann. Intern. Med. 1997; 126: 63-73.
4. 4. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 1991; 91: 507-11.
5. 5. Martino E, Safran M, Aghini-Lombardi F et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 1984; 101: 28-34.
6. 6. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results of a prospective study. J. Clin. Endocrinol. Metab. 1996; 81: 2930-3.
7. 7. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 1994; 78: 423-7.
8. 8. Gibson HB. Surveillance of iodine deficiency disorders in Tasmania, 1949-1984. Report held by the University of Tasmania Library, Hobart.
9. 9. Richards PA. Iodine nutrition in two Tasmanian cultures. Med. J. Aust. 1995; 163: 628-30.
10. 10. Newnham HH, Topliss DJ, Le Grand BA, Chosich N, Harper RW, Stockigt J. Amiodarone-induced hyperthyroidism: Assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate. Aust. N.Z. J. Med. 1987; 18: 37-44.
11. 11. Mulligan DC, McHenry CR, Kinney W, Esseltyn CB. Amiodarone-induced thyrotoxicosis: Clinical presentation and expanded indications for thyroidectomy. Surgery 1993; 114: 1114-19.
12. 12. Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 1990; 263: 1526-8.
13. 13. Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J, Hennen G. Surgical management of amiodarone-associated thyrotoxicosis: Too risky or too effective. World J. Surg. 1998; 22: 537-43.
14. 14. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone associated thyrotoxicosis. Am. J. Surg. Pathol. 1987; 11: 197-204.
15. 15. Bogazzi F, Bartalena L, Brogioni S et al. Color flow doppler sonography rapidly differentiates Type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7: 541-5.
16. 16. Safran M, Martino E, Aghini-Lombardi F et al. Effect of amiodarone on circulating antithyroid antibodies. BMJ 1988; 297: 456-7.
17. 17. Rabinowe SL, Larsen PR, Antman EM et al. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am. J. Med. 1986; 81: 53-7.